| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2094261 | F | MMV: Screen against Mtb, single point, non replicating, at 25uM | Mycobacterium tuberculosis | 399 | organism-based format | MMV Malaria Box | ||
| 2. | ALA2094262 | F | MMV: Screen against Mtb, single point, replicating, at 25uM | Mycobacterium tuberculosis | 399 | organism-based format | MMV Malaria Box | ||
| 3. | ALA2028070 | F | MMV: Inhibition of Plasmodium falciparum 3D7 at 5uM compound concentration. | Plasmodium falciparum | 315 | organism-based format | MMV Malaria Box | ||
| 4. | ALA2028071 | F | MMV: Inhibition of Plasmodium falciparum 3D7 (EC50). | Plasmodium falciparum | 317 | organism-based format | MMV Malaria Box | ||
| 5. | ALA2028073 | F | MMV: Inhibition of Trypanosoma cruzi (Tulahuen C4 LacZ) (Chagas in vitro). | Trypanosoma cruzi | 400 | organism-based format | MMV Malaria Box | ||
| 6. | ALA2028074 | F | MMV: Inhibition of Trypanosoma brucei brucei (Squib 427) (HAT in vitro). | Trypanosoma brucei brucei | 400 | organism-based format | MMV Malaria Box | ||
| 7. | ALA2028075 | F | MMV: Inhibition of Trypanosoma brucei rhodesiense (STIB 900) (HAT in vitro). | Trypanosoma brucei rhodesiense | 400 | organism-based format | MMV Malaria Box | ||
| 8. | ALA2028076 | F | MMV: Inhibition of Leishmania infantum (MHOM/MA/BE/67) in vitro. | Leishmania infantum | 400 | organism-based format | MMV Malaria Box | ||
| 9. | ALA2028077 | T | MMV: Cytotoxicity against human fibroblasts (MRC-5) cells. | Homo sapiens | 400 | cell-based format | MMV Malaria Box | ||
| 10. | ALA2114788 | F | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | Homo sapiens | 103,470 | assay format | PubChem BioAssays | ||
| 11. | ALA1040691 | F | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | Plasmodium falciparum | 5,614 | organism-based format | Novartis Malaria Screening | ||
| 12. | ALA1040692 | F | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | Plasmodium falciparum | 5,614 | organism-based format | Novartis Malaria Screening | ||
| 13. | ALA1040693 | T | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | Homo sapiens | 5,614 | cell-based format | Novartis Malaria Screening | ||
| 14. | ALA1040694 | F | NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested. | 5,614 | assay format | Novartis Malaria Screening | |||
| 15. | ALA1614249 | B | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | Equus caballus | 42,059 | single protein format | PubChem BioAssays | ||
| 16. | ALA1614250 | F | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | Homo sapiens | 20,446 | assay format | PubChem BioAssays | ||
| 17. | ALA1614146 | F | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21. (Class of assay: confirmatory) | Homo sapiens | 31,975 | assay format | PubChem BioAssays | ||
| 18. | ALA1614502 | F | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | 23,781 | assay format | PubChem BioAssays | |||
| 19. | ALA1613836 | F | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Activators of miR-21. (Class of assay: confirmatory) | Homo sapiens | 31,975 | assay format | PubChem BioAssays | ||
| 20. | ALA1738184 | F | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | Homo sapiens | 77,876 | assay format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!